4
Changes in Ownership
MAXCYTE, INC. Filed Acc 0001209191-23-042110
President and CEO sold 30,000 shares at an average $5.03 ($150,852)
- President and CEO acquired 30,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Doerfler Douglas · President and CEO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-07-10 | Exercise or conversion : show line 1 in the form 10b5-1 | +445 | $0.04 | $18 | 333,642 | D |
| 2023-07-10 | Sale : show line 2 in the form 10b5-1 | −445 | $5.01 | $2,229 | 333,197 | D |
| 2023-07-11 | Exercise or conversion : show line 3 in the form 10b5-1 | +12,798 | $0.04 | $512 | 345,995 | D |
| 2023-07-11 | Sale : show line 4 in the form 10b5-1 | −12,798 | $5.04 | $64,502 | 333,197 | D |
| 2023-07-12 | Exercise or conversion : show line 5 in the form 10b5-1 | +16,757 | $0.04 | $670 | 349,954 | D |
| 2023-07-12 | Sale : show line 6 in the form 10b5-1 | −16,757 | $5.02 | $84,120 | 333,197 | D |
| Open-market sales · 30,000 sh · avg $5.03 · $150,852 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-07-10 | Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (right to buy) | −445 | 264,635 | D |
| 2023-07-11 | Exercise or conversion : show line 8 in the form 10b5-1 Employee Stock Option (right to buy) | −12,798 | 251,837 | D |
| 2023-07-12 | Exercise or conversion : show line 9 in the form 10b5-1 Employee Stock Option (right to buy) | −16,757 | 235,080 | D |
Loading xslF345X04/doc4.xml…